OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparison of three immunoassays for infliximab trough level monitoring in paediatric inflammatory bowel diseases
Juliette Villemonteix, Valérie Guérin‐El Khourouj, Jean‐Pierre Hugot, et al.
Biologicals (2021) Vol. 70, pp. 17-21
Closed Access | Times Cited: 4
Juliette Villemonteix, Valérie Guérin‐El Khourouj, Jean‐Pierre Hugot, et al.
Biologicals (2021) Vol. 70, pp. 17-21
Closed Access | Times Cited: 4
Showing 4 citing articles:
90K/Mac-2 BP Is a New Predictive Biomarker of Response to Infliximab Therapy in IBD Patients
Pasqua Letizia Pesole, Marina Liso, Rossella Donghia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3955-3955
Open Access | Times Cited: 4
Pasqua Letizia Pesole, Marina Liso, Rossella Donghia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3955-3955
Open Access | Times Cited: 4
Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA
Teresa Valdés-Delgado, A Aguado-Paredes, Vicente Merino‐Bohórquez, et al.
Digestive Diseases and Sciences (2023) Vol. 69, Iss. 1, pp. 228-234
Open Access | Times Cited: 4
Teresa Valdés-Delgado, A Aguado-Paredes, Vicente Merino‐Bohórquez, et al.
Digestive Diseases and Sciences (2023) Vol. 69, Iss. 1, pp. 228-234
Open Access | Times Cited: 4
Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel Disease
Clarissa Rentsch, Mark G. Ward, Raphael P. Luber, et al.
Therapeutic Drug Monitoring (2022) Vol. 45, Iss. 3, pp. 383-391
Closed Access | Times Cited: 3
Clarissa Rentsch, Mark G. Ward, Raphael P. Luber, et al.
Therapeutic Drug Monitoring (2022) Vol. 45, Iss. 3, pp. 383-391
Closed Access | Times Cited: 3
Comparison of the Pharmacokinetics of CT-P13 Between Crohn’s Disease and Ulcerative Colitis
Eun Soo Kim, Sung Kook Kim, Dong Il Park, et al.
Journal of Clinical Gastroenterology (2022) Vol. 57, Iss. 6, pp. 601-609
Closed Access
Eun Soo Kim, Sung Kook Kim, Dong Il Park, et al.
Journal of Clinical Gastroenterology (2022) Vol. 57, Iss. 6, pp. 601-609
Closed Access
